The miRNAome of the postpartum dairy cow liver in negative energy balance

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Fatima, Attia ^a,b   Lynn, David J ^a   O'Boyle, Padraic ^b   Seoighe, Cathal ^b   Morris, Dermot ^a  

^a ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Dairy cattle; Liver; micro RNA; Negative energy balance; Nutrition; RNA seq

Indexed keywords

MEGALIN; MICRORNA; MICRORNA 122; MICRORNA 143; MICRORNA 192; MICRORNA 22; MICRORNA 3596; MICRORNA LET 7; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAIRY CATTLE; DOWN REGULATION; ENERGY BALANCE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; LIPID METABOLISM; LIVER; MULTIGENE FAMILY; NEGATIVE ENERGY BALANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PUERPERIUM; RNA ANALYSIS; RNA SEQUENCE; TISSUE SPECIFICITY; UPREGULATION;

BOS;

ANIMALS; CATTLE; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER; MICRORNAS; POSTPARTUM PERIOD; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84899484185     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-279     Document Type: Article

References (66)

1. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19(1):92-105. 2612969, 18955434.
2. Fatima A, Morris DG. Review: microRNAs in domestic livestock. Physiol Genomics 2013, 45(16):685-696. 10.1152/physiolgenomics.00009.2013, 23780847.
3. Lee Y, Jeon K, Lee J-T, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002, 21(17):4663-4670. 10.1093/emboj/cdf476, 126204, 12198168.
4. Dumortier O, Hinault C, Van Obberghen E. MicroRNAs and Metabolism Crosstalk in Energy Homeostasis. Cell Metab 2013, 18(3):312-324. 10.1016/j.cmet.2013.06.004, 23850315.
5. Ming M, Zhao X, Zhao Z-Y, Liu B, Bao J-K. MicroRNA regulation of programmed cell death pathways in cancer. Curr Chem Biol 2012, 6(1):53-59.
6. Pandey AK, Agarwal P, Kaur K, Datta M. MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem 2009, 23(4-6):221-232.
7. Alisi A, Da Sacco L, Bruscalupi G, Piemonte F, Panera N, De Vito R, Leoni S, Bottazzo GF, Masotti A, Nobili V. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 2010, 91(2):283-293.
8. Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009, 15(45):5633-5640. 10.3748/wjg.15.5633, 2789214, 19960558.
9. Tsai W-C, Hsu S-D, Hsu C-S, Lai T-C, Chen S-J, Shen R, Huang Y, Chen H-C, Lee C-H, Tsai T-F. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012, 122(8):2884-2897. 10.1172/JCI63455, 3408747, 22820290.
10. Gu Z, Eleswarapu S, Jiang H. Identification and characterization of microRNAs from the bovine adipose tissue and mammary gland. FEBS Lett 2007, 581(5):981-988. 10.1016/j.febslet.2007.01.081, 17306260.
11. Jin W, Grant JR, Stothard P, Moore SS, Guan LL. Characterization of bovine miRNAs by sequencing and bioinformatics analysis. BMC Mol Biol 2009, 10(1):90. 10.1186/1471-2199-10-90, 2761914, 19758457.
12. Becker C, Riedmaier I, Reiter M, Tichopad A, Pfaffl MW, Meyer HHD. Changes in the miRNA profile under the influence of anabolic steroids in bovine liver. Analyst 2011, 136(6):1204-1209. 10.1039/c0an00703j, 21212882.
13. Nicholas LM, Rattanatray L, MacLaughlin SM, Ozanne SE, Kleemann DO, Walker SK, Morrison JL, Zhang S, Muhlhäusler BS, Martin-Gronert MS. Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring. FASEB J 2013, 27(9):3786-3796. 10.1096/fj.13-227918, 23729590.
14. Sheldon IM. The postpartum uterus. Vet Clin North Am Food Anim Pract 2004, 20(3):569-591. 10.1016/j.cvfa.2004.06.008, 15471625.
15. Wathes DC, Fenwick MA, Llewellyn S, Cheng Z, Fitzpatrick R, McCarthy SD, Morris DG, Patton J, Murphy JJ. Influence of energy balance on gene expression in the liver and reproductive tract of lactating cows and consequent effects on fertility. XXV Jubilee World Buiatrics Congress Hungarian Association for Buiatrics 2008 2008, 158-171. Budapest, Hungary, http://www.blaguss-congress.hu/xxvwbc2008/pdf/programmebook.pdf.
16. Liu GW, Zhang ZG, Wang JG, Wang Z, Xu C, Zhu XL. Insulin receptor gene expression in normal and diseased bovine liver. J Comp Pathol 2010, 143(4):258-261. 10.1016/j.jcpa.2010.04.004, 20627313.
17. Thomas C, Leach K, Logue D, Ferris C, Phipps R. Management options to reduce load. Cattle Pract 1999, 7:121-122.
18. Patton J, Kenny D, Mee J, O'Mara F, Wathes D, Cook M, Murphy J. Effect of milking frequency and diet on milk production, energy balance, and reproduction in dairy cows. J Dairy Sci 2006, 89:1478-1487. 10.3168/jds.S0022-0302(06)72215-9, 16606718.
19. McCarthy SD, Waters SM, Kenny DA, Diskin MG, Fitzpatrick R, Patton J, Wathes DC, Morris DG. Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach. Physiol Genomics 2010, 42(3):188-199.
20. McCabe M, Waters S, Morris D, Kenny D, Lynn D, Creevey C. RNA-seq analysis of differential gene expression in liver from lactating dairy cows divergent in negative energy balance. BMC Genomics 2012, 13(1):193. 10.1186/1471-2164-13-193, 3465249, 22607119.
21. Fatima A, Waters S, O'Boyle P, Seoighe C, Morris D. Alterations in hepatic miRNA expression during negative energy balance in postpartum dairy cattle. BMC Genomics 2014, 15:28. 10.1186/1471-2164-15-28, 3902422, 24428929.
22. Gunaratne PH, Coarfa C, Soibam B, Tandon A. miRNA data analysis: next-gen sequencing. Methods Mol Biol 2012, 822:273-288. 10.1007/978-1-61779-427-8_19, 22144206.
23. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell 2012, 149(3):515-524. 10.1016/j.cell.2012.04.005, 3351105, 22541426.
24. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009, 15(1):31-33. 10.1038/nm.1902, 19122656.
25. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, Zingale A, Baccarini A, Lazzari G, Galli C, Naldini L. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007, 25(12):1457-1467. 10.1038/nbt1372, 18026085.
26. Garber M, Grabherr MG, Guttman M, Trapnell C. Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 2011, 8(6):469-477. 10.1038/nmeth.1613, 21623353.
27. Kaur K, Pandey AK, Srivastava S, Srivastava AK, Datta M. Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver. Mol Biosyst 2011, 7(12):3234-3244. 10.1039/c1mb05041a, 21968817.
28. Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S. Roles of microRNA on cancer cell metabolism. J Transl Med 2012, 10:228. 10.1186/1479-5876-10-228, 3563491, 23164426.
29. Rottiers V, Naarr AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 2012, 13(4):239-250. 10.1038/nrm3313, 22436747.
30. Jopling C. Liver-specific microRNA-122: Biogenesis and function. RNA Biol 2012, 9(2):137-142. 10.4161/rna.18827, 3346312, 22258222.
31. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011, 19(2):232-243. 10.1016/j.ccr.2011.01.001, 21316602.
32. Zeng C, Wang R, Li D, Lin XJ, Wei QK, Yuan Y, Wang Q, Chen W, Zhuang SM. A novel GSK 3 beta C/EBP alpha miR-122 insulin like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 2010, 52(5):1702-1712. 10.1002/hep.23875, 21038412.
33. Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 2010, 90(10):1437-1446. 10.1038/labinvest.2010.113, 20548288.
34. Li N, You X, Chen T, Mackowiak SD, Friedlander MR, Weigt M, Du H, Gogol-Doring A, Chang Z, Dieterich C. Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery. Nucleic Acids Res 2013, 41(6):3619-3634. 10.1093/nar/gkt072, 3616697, 23396444.
35. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci 2009, 106(11):4402-4407. 10.1073/pnas.0813371106, 2657429, 19246379.
36. Chung ACK, Huang XR, Meng X, Lan HY. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 2010, 21(8):1317-1325. 10.1681/ASN.2010020134, 2938591, 20488955.
37. Coutinho LL, Matukumalli LK, Sonstegard TS, Van Tassell CP, Gasbarre LC, Capuco AV, Smith TPL. Discovery and profiling of bovine microRNAs from immune-related and embryonic tissues. Physiol Genomics 2007, 29(1):35-43.
38. Tesfaye D, Worku D, Rings F, Phatsara C, Tholen E, Schellander K, Hoelker M. Identification and expression profiling of microRNAs during bovine oocyte maturation using heterologous approach. Mol Reprod Dev 2009, 76(7):665-677. 10.1002/mrd.21005, 19170227.
39. Ma J, Jiang Z, He S, Liu Y, Chen L, Long K, Jin L, Jiang A, Zhu L, Wang J, Li M, Li X. Intrinsic Features in MicroRNA Transcriptomes Link Porcine Visceral Rather than Subcutaneous Adipose Tissues to Metabolic Risk. PLoS One 2013, 8(11):e80041. 10.1371/journal.pone.0080041, 3819305, 24223210.
40. Hou W, Tian Q, Steuerwald NM, Schrum LW, Bonkovsky HL. The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim Biophys Acta(BBA)-Gene Regulatory Mechanisms 2012, 1819(11):1113-1122.
41. Ji J, Zhao L, Budhu A, Forgues M, Jia H-L, Qin L-X, Ye Q-H, Yu J, Shi X, Tang Z-Y. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010, 52(5):690-697. 10.1016/j.jhep.2009.12.025, 2862772, 20338660.
42. Ferland-McCollough D, Ozanne S, Siddle K, Willis A, Bushell M. The involvement of microRNAs in Type2 diabetes. Biochem Soc Trans 2010, 38(6):1565-1570. 10.1042/BST0381565, 21118127.
43. Fowell AJ, Sanchez-Elsner T, Benyon RC, Rosenberg WM, Collins JE. Differential expression of microRNAs during hepatic stellate cell activation and their role in the regulation of hepatic stellate cell proliferation and apoptosis. Gut 2010, 59(Suppl 2):A8.
44. Zheng L, Lv G, Sheng J, Yang Y. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-α expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 2010, 25(1):156-163. 10.1111/j.1440-1746.2009.05949.x, 19780876.
45. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA 143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50(2):490-499. 10.1002/hep.23008, 19472311.
46. Trakooljul N, Hicks JA, Liu H. Identification of target genes and pathways associated with chicken microRNA miR-143. Anim Genet 2010, 41(4):357-364.
47. Jordan SD, Krager M, Willmes DM, Redemann N, Wunderlich FT, Branneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Battger T. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 2011, 13(4):434-446. 10.1038/ncb2211, 21441927.
48. Ono K. MicroRNA links obesity and impaired glucose metabolism. Cell Res 2011, 21(6):864-866. 10.1038/cr.2011.78, 3203709, 21556034.
49. Li H, Zhang Z, Zhou X, Wang Z, Wang G, Han Z. Effects of microRNA-143 in the differentiation and proliferation of bovine intramuscular preadipocytes. Mol Biol Rep 2011, 38(7):4273-4280. 10.1007/s11033-010-0550-z, 21113671.
50. Jin W, Dodson MV, Moore SS, Basarab JA. Characterization of microRNA expression in bovine adipose tissues: a potential regulatory mechanism of subcutaneous adipose tissue development. BMC Mol Biol 2010, 11(1):29. 10.1186/1471-2199-11-29, 2874793, 20423511.
51. Harfoot CG, Hazlewood GP. Lipid metabolism in the rumen. The Rumen Microbial Ecosystem 1997, 382-426. Netherlands: Springer.
52. Grummer RR. Etiology of lipid-related metabolic disorders in periparturient dairy cows. J Dairy Sci 1993, 76(12):3882-3896. 10.3168/jds.S0022-0302(93)77729-2, 8132893.
53. Willnow TE, Hammes A, Eaton S. Lipoproteins and their receptors in embryonic development: more than cholesterol clearance. Development 2007, 134(18):3239-3249. 10.1242/dev.004408, 17720693.
54. May P, Woldt E, Matz RL, Boucher P. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med 2007, 39(3):219-228. 10.1080/07853890701214881, 17457719.
55. Dahlback B, Nielsen LB. Apolipoprotein M-a novel player in high-density lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 2006, 17(3):291-295. 10.1097/01.mol.0000226122.10005.88, 16680035.
56. Dahlback B, Nielsen LB. Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?. Cell Mol Life Sci 2009, 66(4):559-564. 10.1007/s00018-009-8764-8, 19153651.
57. Faber K, Hvidberg V, Moestrup SK, Dahlback B, Nielsen LB. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol Endocrinol 2006, 20(1):212-218. 10.1210/me.2005-0209, 16099815.
58. Perri R, Nares S, Zhang S, Barros SP, Offenbacher S. MicroRNA modulation in obesity and periodontitis. J Dent Res 2012, 91(1):33-38. 10.1177/0022034511425045, 3232116, 22043006.
59. Cock P, Fields C, Goto N, Heuer M, Rice P. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res 2010, 38:1767-1771. 10.1093/nar/gkp1137, 2847217, 20015970.
60. Garmire LX, Subramaniam S. Evaluation of normalization methods in mammalian microRNA-Seq data. RNA 2012, 18(6):1279-1288. 10.1261/rna.030916.111, 3358649, 22532701.
61. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Soc Stat Soc Ser B (Methodological) 1995, 57(1):289-300.
62. Schmittgen T, Livak K. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008, 3(6):1101-1108. 10.1038/nprot.2008.73, 18546601.
63. Yuan J, Reed A, Chen F, Stewart C. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7(1):85. 10.1186/1471-2105-7-85, 1395339, 16504059.
64. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA Targeting Specificity in Mammals: determinants beyond Seed Pairing. Mol Cell 2007, 27(1):91-105. 10.1016/j.molcel.2007.06.017, 3800283, 17612493.
65. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20. 10.1016/j.cell.2004.12.035, 15652477.
66. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36(suppl 1):D149-D153. 2238905, 18158296.